CN1538966A - 喹唑啉酮衍生物 - Google Patents
喹唑啉酮衍生物 Download PDFInfo
- Publication number
- CN1538966A CN1538966A CNA028154843A CN02815484A CN1538966A CN 1538966 A CN1538966 A CN 1538966A CN A028154843 A CNA028154843 A CN A028154843A CN 02815484 A CN02815484 A CN 02815484A CN 1538966 A CN1538966 A CN 1538966A
- Authority
- CN
- China
- Prior art keywords
- acceptable salt
- pharmaceutical acceptable
- optically
- formula
- quinazolinone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
实施例号 | 收缩幅度ED30(mg/kg) | 收缩频率ED30(mg/kg) |
1(盐酸盐) | 1.71 | 1.31 |
2-1(盐酸盐) | 1.09 | 0.70 |
2-3(盐酸盐) | 1.10 | 1.54 |
2-4(盐酸盐) | 1.42 | 1.35 |
3(盐酸盐) | 0.94 | 1.79 |
Claims (13)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP241955/2001 | 2001-08-09 | ||
JP2001241955 | 2001-08-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1538966A true CN1538966A (zh) | 2004-10-20 |
CN1307172C CN1307172C (zh) | 2007-03-28 |
Family
ID=19072309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028154843A Expired - Fee Related CN1307172C (zh) | 2001-08-09 | 2002-08-02 | 喹唑啉酮衍生物 |
Country Status (13)
Country | Link |
---|---|
US (1) | US7329665B2 (zh) |
EP (1) | EP1424334B1 (zh) |
JP (1) | JP4087337B2 (zh) |
KR (1) | KR100824506B1 (zh) |
CN (1) | CN1307172C (zh) |
AT (1) | ATE376546T1 (zh) |
CA (1) | CA2457351C (zh) |
DE (1) | DE60223151T2 (zh) |
DK (1) | DK1424334T3 (zh) |
ES (1) | ES2295382T3 (zh) |
PT (1) | PT1424334E (zh) |
TW (1) | TWI308567B (zh) |
WO (1) | WO2003016299A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101945657B (zh) * | 2008-02-11 | 2015-04-22 | 大日本住友制药株式会社 | 具有改善的溶出性的片剂 |
WO2010053068A1 (ja) | 2008-11-07 | 2010-05-14 | 大日本住友製薬株式会社 | 新規で有用な下部尿路症状治療剤 |
KR20180011840A (ko) * | 2015-06-12 | 2018-02-02 | 비샬 자조디아 스와티 | 방광 출구 폐쇄 및/또는 하부 요로 증상의 치료에서 사용하기 위한 펜토산폴리설페이트나트륨을 포함하는 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0626373B1 (en) * | 1993-05-26 | 1998-12-23 | Sumitomo Pharmaceuticals Company, Limited | Quinazolinone derivatives |
EP1122253B1 (en) | 1998-10-16 | 2005-08-17 | Sumitomo Pharmaceuticals Company, Limited | Quinazolinone derivatives |
-
2002
- 2002-08-02 DK DK02755797T patent/DK1424334T3/da active
- 2002-08-02 DE DE60223151T patent/DE60223151T2/de not_active Expired - Lifetime
- 2002-08-02 EP EP02755797A patent/EP1424334B1/en not_active Expired - Lifetime
- 2002-08-02 ES ES02755797T patent/ES2295382T3/es not_active Expired - Lifetime
- 2002-08-02 WO PCT/JP2002/007930 patent/WO2003016299A1/ja active IP Right Grant
- 2002-08-02 CN CNB028154843A patent/CN1307172C/zh not_active Expired - Fee Related
- 2002-08-02 KR KR1020047001829A patent/KR100824506B1/ko not_active IP Right Cessation
- 2002-08-02 US US10/485,865 patent/US7329665B2/en not_active Expired - Lifetime
- 2002-08-02 PT PT02755797T patent/PT1424334E/pt unknown
- 2002-08-02 AT AT02755797T patent/ATE376546T1/de active
- 2002-08-02 CA CA002457351A patent/CA2457351C/en not_active Expired - Fee Related
- 2002-08-02 JP JP2003521223A patent/JP4087337B2/ja not_active Expired - Fee Related
- 2002-08-09 TW TW091118017A patent/TWI308567B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI308567B (zh) | 2009-04-11 |
KR20040020081A (ko) | 2004-03-06 |
ATE376546T1 (de) | 2007-11-15 |
PT1424334E (pt) | 2008-01-10 |
ES2295382T3 (es) | 2008-04-16 |
KR100824506B1 (ko) | 2008-04-22 |
EP1424334B1 (en) | 2007-10-24 |
DE60223151T2 (de) | 2008-08-07 |
CA2457351A1 (en) | 2003-02-27 |
CN1307172C (zh) | 2007-03-28 |
EP1424334A4 (en) | 2005-05-04 |
EP1424334A1 (en) | 2004-06-02 |
WO2003016299A1 (fr) | 2003-02-27 |
US20050032819A1 (en) | 2005-02-10 |
DK1424334T3 (da) | 2008-02-11 |
JPWO2003016299A1 (ja) | 2004-12-02 |
CA2457351C (en) | 2010-01-12 |
JP4087337B2 (ja) | 2008-05-21 |
DE60223151D1 (de) | 2007-12-06 |
US7329665B2 (en) | 2008-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1101391C (zh) | 抑制法呢基转移酶的2-喹诺酮衍生物 | |
CN1022566C (zh) | 制备新的取代的1-哌啶亚烷基-吡啶并嘧啶酮或噻唑并嘧啶酮的方法 | |
CN1284066A (zh) | 对α2B或2B/2C肾上腺素能受体具有激动剂样活性的取代咪唑衍生物 | |
CN1671387A (zh) | 芳基取代的乙内酰脲化合物及其作为钠通道阻滞剂的应用 | |
CN1784230A (zh) | 烟碱性乙酰胆碱受体的正向调节剂 | |
WO1999025345A1 (en) | Alpha-1a adrenergic receptor antagonists | |
CN1152857C (zh) | 用作多巴胺受体的苯磺酰胺-苯乙胺 | |
CA2294344A1 (en) | Alpha 1a adrenergic receptor antagonists | |
CN1538966A (zh) | 喹唑啉酮衍生物 | |
JP5788397B2 (ja) | ケモカイン受容体活性の調節薬としてのピペリジニル誘導体のプロドラッグ | |
JP2006188466A (ja) | 過活動膀胱治療薬としてのキナゾリノン誘導体 | |
CN1247593C (zh) | 噻庚英并[3,2-b]二氢吡啶和相关组合物及方法 | |
US6080760A (en) | Alpha 1A adrenergic receptor antagonists | |
WO2015046405A1 (ja) | 鎮痛剤 | |
CN1278249A (zh) | 用作药物的联苯基衍生物 | |
US6376503B1 (en) | Alpha 1a adrenergic receptor antagonists | |
US6339090B1 (en) | Alpha 1A adrenergic receptor antagonists | |
CN100335483C (zh) | 具有镇痛作用的新型双哌嗪季铵盐类化合物 | |
CN1109673C (zh) | 制备用作iv型磷酸二酯酶抑制剂的4-氰基-4-(取代吲唑)环己烷羧酸的改良方法 | |
US6235759B1 (en) | Dihydropyridinones and pyrrolinones useful as alpha 1A adrenoceptor antagonists | |
CN1234694C (zh) | 新的咪唑啉化合物、其制备方法及包含它们的药物组合物 | |
CN1100099A (zh) | 喹啉基-二氢吡啶酯类化合物及其制备和作为药物的用途 | |
CN1032136C (zh) | 双氢吡啶-3,5-双羧酸酯衍生物的制备方法 | |
CN1306511A (zh) | 新的杂环化合物 | |
JPH11507395A (ja) | アルファ1a アドレナリン受容体拮抗薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: NIPPO SUMITOMO PHARMACEUTICALS CO., LTD. Free format text: FORMER OWNER: SUMITOMO PHARMACEUTICALS CO., LTD. Effective date: 20060414 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20060414 Address after: Osaka City, Osaka of Japan Applicant after: Dainippon Sumitomo Pharma Co., Ltd. Address before: Osaka Japan Applicant before: Sumitomo Chemical Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070328 Termination date: 20160802 |
|
CF01 | Termination of patent right due to non-payment of annual fee |